A detailed history of Mather Group, Llc. transactions in Embecta Corp. stock. As of the latest transaction made, Mather Group, Llc. holds 10 shares of EMBC stock, worth $202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 40 75.0%
Holding current value
$202
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$11.46 - $16.56 $343 - $496
-30 Reduced 75.0%
10 $0
Q2 2024

Jul 08, 2024

BUY
$10.13 - $14.6 $222 - $321
22 Added 122.22%
40 $0
Q1 2024

Apr 08, 2024

BUY
$12.35 - $19.33 $222 - $347
18 New
18 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.